Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia.
| Autor: | Castro, J. E.1,2, Sandoval-Sus, J. D.1,2, Bole, J.1,2, Rassenti, L.1,2, Kipps, T. J.1,2 tkipps@ucsd.edu |
|---|---|
| Zdroj: | Leukemia (08876924). Nov2008, Vol. 22 Issue 11, p2048-2053. 6p. 2 Charts, 2 Graphs. |
| Databáze: | Academic Search Ultimate |
| Externí odkaz: |
|